Orthogonal NGS for High Throughput Clinical Diagnostics

Area of Science:

• Genomics
• Molecular Biology
• Clinical Diagnostics

Background:

• Next-generation sequencing (NGS) is crucial for genetic disorder discovery and diagnosis.
• High-throughput sequencing technologies are prone to errors, requiring variant confirmation for clinical applications.

Purpose of the Study:

• To develop an orthogonal, dual-platform approach for enhanced accuracy and speed in genomic variant calling.
• To improve the reliability of genetic variant detection for clinical diagnostics.

Main Methods:

• Combined bait-based hybridization (Illumina NextSeq) with amplification-based selection (Ion Proton).
• Employed complementary target capture and sequencing chemistries for orthogonal confirmation.
• Applied this dual-platform strategy at a genomic scale.

Main Results:

• Achieved orthogonal confirmation of approximately 95% of exome variants.
• Improved overall variant sensitivity by leveraging the complementary coverage of each method.
• Demonstrated enhanced specificity for variants identified on both platforms.

Conclusions:

• Orthogonal NGS using two platforms significantly improves variant calling sensitivity and specificity.
• This approach reduces the time and cost associated with traditional Sanger sequencing follow-up.
• Enables faster clinical decision-making based on reliable genomic results.